Targeted Radiotherapy Injection Shrinks Treatment-resistant Prostate Cancer Tumours in Early Clinical Trial
February 28, 2026
February 28, 2026
LONDON, England, Feb. 28 -- The Royal Marsden National Health Service Foundation Trust issued the following news:
* * *
Targeted radiotherapy injection shrinks treatment-resistant prostate cancer tumours in early clinical trial
The 'search and destroy' treatment shrank tumours or halted their growth in 83 per cent of patients on the phase I trial.
*
A new drug for prostate cancer, which delivers a precisely targeted dose . . .
* * *
Targeted radiotherapy injection shrinks treatment-resistant prostate cancer tumours in early clinical trial
The 'search and destroy' treatment shrank tumours or halted their growth in 83 per cent of patients on the phase I trial.
*
A new drug for prostate cancer, which delivers a precisely targeted dose . . .